EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches

Zhi-Hong Ning, Xiu-Heng Wang, Yue Zhao, Yun Ou, Jia-Yan Yang, Hui-Fang Tang, Heng-Jing Hu

International Immunopharmacology · 2025-04 · 151 · 114341

DOI: 10.1016/j.intimp.2025.114341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Zhi-Hong Ning und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Department of Cardiovascular Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, PR …. Hauptthemen laut MEDLINE: Ferroptosis, Fibrosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 194 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, a form of iron-dependent regulated cell death, has emerged as a critical mechanism in the pathogenesis of organ fibrosis. This review aims to provide an overview of the molecular mechanisms underlying ferroptosis and its contribution to fibrosis in various organs, including the liver, lung, heart, and kidneys. We explore how dysregulated iron metabolism, lipid peroxidation, and oxidative stress contribute to ferroptosis and subsequent tissue damage, promoting the progression of fibrosis. In addition, we highlight the complex interplay between ferroptosis and other cellular processes such as apoptosis, necrosis, and inflammation in the fibrotic microenvironment. Furthermore, this review discusses current therapeutic strategies targeting ferroptosis, including iron chelation, antioxidants, and modulators of lipid peroxidation. We also examine ongoing clinical and preclinical studies aimed at translating these findings into viable treatments for fibrotic diseases. Understanding the role of ferroptosis in organ fibrosis offers novel therapeutic opportunities, with the potential to mitigate disease progression and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisFibrosisHumansAnimalsIronOxidative StressLipid PeroxidationAntioxidants

Stichwörter der Autor:innen

AntioxidantsFerroptosisIron metabolismLipid peroxidationOrgan fibrosisTherapeutic strategies

Substanzen

IronAntioxidants

Autor:innen und Institutionen

  • The First Affiliated Hospital, Department of Cardiovascular Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, PR China.
  • The First Affiliated Hospital, Department of Medical-Record, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, PR China.
  • The First Affiliated Hospital, Department of Cardiovascular Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, PR China; Department of Cardiovascular Disease and Key Lab for Atheroscle…

Zitieren

APA

Ning, Z. H., Wang, X. H., Zhao, Y., Ou, Y., Yang, J. Y., Tang, H. F., & Hu, H. J. (2025). Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches. International Immunopharmacology, 151, 114341. https://doi.org/10.1016/j.intimp.2025.114341

Vancouver

Ning ZH, Wang XH, Zhao Y, Ou Y, Yang JY, Tang HF, et al. Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches. International Immunopharmacology. 2025;151:114341. doi:10.1016/j.intimp.2025.114341

BibTeX
@article{Ning2025,
  author = {Ning, Zhi-Hong and Wang, Xiu-Heng and Zhao, Yue and Ou, Yun and Yang, Jia-Yan and Tang, Hui-Fang and Hu, Heng-Jing},
  title = {Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {151},
  pages = {114341},
  doi = {10.1016/j.intimp.2025.114341}
}
Kostenlos starten →